LexaGene Holdings Inc. (LXXGF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 04:59PM EDT
| Previous Close | 0.0806 |
| Open | 0.0860 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0806 - 0.0806 |
| 52 Week Range | 0.0496 - 0.2213 |
| Volume | |
| Avg. Volume | 210,932 |
| Market Cap | 11.336M |
| Beta (5Y Monthly) | 2.04 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0950 |
| Earnings Date | Jan 17, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
LexaGene Files for Chapter 7 Bankruptcy
BEVERLY, Mass., Feb. 24, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), announces that it has ceased operations, laid off its staff, and, together with its direct subsidiary LexaGene, Inc., and its indirect subsidiary Bionomics Diagnostics, Inc., filed a voluntary petition for relief under Chapter 7 of the U.S. Bankruptcy Code. The filing, which took place earlier today at the U.S. Bankruptcy Court for the District of Massachusetts, lo
© 2023 Yahoo. All rights reserved.
